| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 11 | 2021 | 325 | 2.400 |
Why?
|
| Ethanol | 14 | 2026 | 333 | 2.310 |
Why?
|
| Myelin Sheath | 3 | 2026 | 38 | 1.950 |
Why?
|
| Prefrontal Cortex | 7 | 2018 | 128 | 1.790 |
Why?
|
| Alcoholism | 10 | 2020 | 329 | 1.730 |
Why?
|
| Gyrus Cinguli | 3 | 2026 | 59 | 1.590 |
Why?
|
| Corpus Callosum | 2 | 2026 | 42 | 1.510 |
Why?
|
| Binge Drinking | 3 | 2026 | 39 | 1.500 |
Why?
|
| Axons | 2 | 2026 | 124 | 1.460 |
Why?
|
| Rats | 26 | 2021 | 1996 | 1.190 |
Why?
|
| Sex Characteristics | 6 | 2026 | 213 | 1.160 |
Why?
|
| Rats, Wistar | 18 | 2021 | 184 | 1.080 |
Why?
|
| Oligodendroglia | 1 | 2026 | 39 | 0.970 |
Why?
|
| Amidohydrolases | 1 | 2026 | 36 | 0.960 |
Why?
|
| Central Nervous System Depressants | 6 | 2014 | 46 | 0.870 |
Why?
|
| Hippocampus | 5 | 2021 | 276 | 0.760 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 7 | 2016 | 27 | 0.690 |
Why?
|
| Limbic System | 1 | 2021 | 27 | 0.690 |
Why?
|
| Corticotropin-Releasing Hormone | 7 | 2016 | 38 | 0.680 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 274 | 0.670 |
Why?
|
| Self Administration | 11 | 2021 | 51 | 0.660 |
Why?
|
| Conditioning, Operant | 6 | 2021 | 29 | 0.660 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2015 | 86 | 0.650 |
Why?
|
| Animals | 37 | 2026 | 21380 | 0.620 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 350 | 0.610 |
Why?
|
| Testosterone | 5 | 2004 | 128 | 0.590 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2004 | 88 | 0.590 |
Why?
|
| Neural Conduction | 1 | 2018 | 32 | 0.570 |
Why?
|
| Action Potentials | 1 | 2018 | 113 | 0.550 |
Why?
|
| Glucocorticoids | 2 | 2015 | 190 | 0.470 |
Why?
|
| Male | 34 | 2026 | 31186 | 0.460 |
Why?
|
| Stress, Psychological | 4 | 2016 | 475 | 0.430 |
Why?
|
| Alcohol-Related Disorders | 1 | 2014 | 37 | 0.410 |
Why?
|
| Pyrimidines | 6 | 2016 | 144 | 0.400 |
Why?
|
| Anxiety | 4 | 2012 | 427 | 0.390 |
Why?
|
| White Matter | 1 | 2014 | 128 | 0.390 |
Why?
|
| Amygdala | 3 | 2015 | 85 | 0.390 |
Why?
|
| Prosencephalon | 2 | 2004 | 37 | 0.390 |
Why?
|
| RNA, Messenger | 6 | 2021 | 1575 | 0.360 |
Why?
|
| Neuroglia | 2 | 2009 | 81 | 0.350 |
Why?
|
| Neurogenesis | 2 | 2009 | 64 | 0.350 |
Why?
|
| Behavior, Addictive | 5 | 2020 | 75 | 0.310 |
Why?
|
| Sexual Maturation | 3 | 2004 | 52 | 0.300 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2008 | 1 | 0.290 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 11 | 0.290 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 755 | 0.280 |
Why?
|
| Nervous System | 1 | 2008 | 71 | 0.270 |
Why?
|
| Anti-Anxiety Agents | 1 | 2007 | 31 | 0.260 |
Why?
|
| Pheromones | 2 | 2004 | 22 | 0.260 |
Why?
|
| Age Factors | 4 | 2018 | 1592 | 0.260 |
Why?
|
| Luteinizing Hormone | 2 | 2004 | 101 | 0.260 |
Why?
|
| Female | 17 | 2026 | 34193 | 0.250 |
Why?
|
| Pituitary-Adrenal System | 3 | 2015 | 59 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2016 | 857 | 0.230 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1039 | 0.230 |
Why?
|
| Cell Count | 3 | 2012 | 128 | 0.230 |
Why?
|
| Palliative Care | 2 | 2019 | 250 | 0.220 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 59 | 0.200 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2014 | 28 | 0.180 |
Why?
|
| Brain | 6 | 2015 | 1611 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 663 | 0.180 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2009 | 126 | 0.180 |
Why?
|
| Mesocricetus | 5 | 2004 | 92 | 0.180 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 2305 | 0.170 |
Why?
|
| Neurons | 3 | 2016 | 934 | 0.170 |
Why?
|
| State Medicine | 1 | 2021 | 12 | 0.170 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2015 | 28 | 0.170 |
Why?
|
| Cervical Ripening | 1 | 2021 | 11 | 0.170 |
Why?
|
| Mice | 4 | 2026 | 11137 | 0.170 |
Why?
|
| Cricetinae | 5 | 2004 | 363 | 0.170 |
Why?
|
| Behavior, Animal | 6 | 2008 | 234 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2026 | 3488 | 0.150 |
Why?
|
| Administration, Inhalation | 3 | 2009 | 160 | 0.150 |
Why?
|
| Rats, Inbred Strains | 3 | 2015 | 150 | 0.150 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2009 | 23 | 0.150 |
Why?
|
| Avoidance Learning | 2 | 2016 | 27 | 0.150 |
Why?
|
| Specialization | 1 | 2019 | 82 | 0.140 |
Why?
|
| Models, Organizational | 1 | 2019 | 93 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 133 | 0.140 |
Why?
|
| Methamphetamine | 2 | 2008 | 25 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1631 | 0.130 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 24 | 0.130 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2016 | 5 | 0.120 |
Why?
|
| Hyperalgesia | 1 | 2016 | 15 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2017 | 169 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 40 | 0.120 |
Why?
|
| Nicotine | 2 | 2007 | 118 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2008 | 156 | 0.110 |
Why?
|
| Depression | 2 | 2012 | 903 | 0.110 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 137 | 0.110 |
Why?
|
| Sexual Behavior, Animal | 3 | 2004 | 88 | 0.110 |
Why?
|
| Humans | 15 | 2021 | 65462 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 160 | 0.100 |
Why?
|
| Pregnancy | 3 | 2021 | 2391 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2016 | 263 | 0.100 |
Why?
|
| Naltrexone | 3 | 2009 | 91 | 0.100 |
Why?
|
| Research Design | 1 | 2016 | 590 | 0.100 |
Why?
|
| Evoked Potentials, Visual | 1 | 2012 | 13 | 0.100 |
Why?
|
| Adolescent | 3 | 2020 | 6332 | 0.100 |
Why?
|
| Brain Waves | 1 | 2012 | 8 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 350 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2012 | 27 | 0.090 |
Why?
|
| Bromodeoxyuridine | 2 | 2009 | 44 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2012 | 76 | 0.090 |
Why?
|
| Anhedonia | 1 | 2012 | 9 | 0.090 |
Why?
|
| Ki-67 Antigen | 2 | 2009 | 37 | 0.090 |
Why?
|
| Food Preferences | 2 | 2009 | 52 | 0.090 |
Why?
|
| Sex Factors | 2 | 2006 | 995 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2012 | 32 | 0.090 |
Why?
|
| Corticosterone | 2 | 2008 | 24 | 0.090 |
Why?
|
| Neuropeptides | 2 | 2009 | 81 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2009 | 116 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 296 | 0.080 |
Why?
|
| Microdialysis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cell Death | 2 | 2008 | 289 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1263 | 0.080 |
Why?
|
| Fluoresceins | 1 | 2009 | 31 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 160 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 624 | 0.070 |
Why?
|
| Nipples | 1 | 2009 | 14 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2012 | 284 | 0.070 |
Why?
|
| Stress, Physiological | 2 | 2015 | 210 | 0.070 |
Why?
|
| Heroin | 1 | 2009 | 10 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2009 | 34 | 0.070 |
Why?
|
| Organic Chemicals | 1 | 2009 | 27 | 0.070 |
Why?
|
| Triazines | 1 | 2009 | 22 | 0.070 |
Why?
|
| Heroin Dependence | 1 | 2009 | 21 | 0.070 |
Why?
|
| Long-Term Potentiation | 1 | 2009 | 42 | 0.070 |
Why?
|
| Mastectomy | 1 | 2009 | 56 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2009 | 46 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2009 | 108 | 0.070 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2008 | 19 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2016 | 3155 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2008 | 9 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2009 | 47 | 0.070 |
Why?
|
| Hearing | 1 | 2008 | 31 | 0.070 |
Why?
|
| Feminization | 1 | 2008 | 2 | 0.070 |
Why?
|
| Dentate Gyrus | 1 | 2008 | 12 | 0.070 |
Why?
|
| Cocaine | 1 | 2009 | 101 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 884 | 0.070 |
Why?
|
| Septal Nuclei | 1 | 2009 | 54 | 0.070 |
Why?
|
| Alcohol Deterrents | 1 | 2008 | 6 | 0.070 |
Why?
|
| Deafness | 1 | 2008 | 36 | 0.070 |
Why?
|
| Thiophenes | 1 | 2008 | 31 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 66 | 0.070 |
Why?
|
| Environment | 1 | 2008 | 125 | 0.070 |
Why?
|
| Cell Survival | 1 | 2009 | 587 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2007 | 47 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 197 | 0.060 |
Why?
|
| Reproduction | 2 | 2004 | 99 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 133 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 377 | 0.060 |
Why?
|
| Ligands | 1 | 2007 | 414 | 0.060 |
Why?
|
| Genomics | 1 | 2009 | 385 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 10 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 897 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 56 | 0.060 |
Why?
|
| Diet | 1 | 2009 | 536 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1386 | 0.060 |
Why?
|
| Time Factors | 3 | 2009 | 3774 | 0.060 |
Why?
|
| Smell | 1 | 2004 | 29 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 309 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 2004 | 8 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 36 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2003 | 5 | 0.050 |
Why?
|
| Preoptic Area | 1 | 2003 | 49 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 248 | 0.050 |
Why?
|
| Testis | 1 | 2004 | 160 | 0.050 |
Why?
|
| Dopamine | 1 | 2003 | 108 | 0.050 |
Why?
|
| Body Weight | 1 | 2004 | 376 | 0.050 |
Why?
|
| Orchiectomy | 1 | 2002 | 40 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2002 | 48 | 0.050 |
Why?
|
| Silver | 1 | 2002 | 15 | 0.050 |
Why?
|
| Puberty | 1 | 2002 | 59 | 0.040 |
Why?
|
| Androgens | 1 | 2002 | 66 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 213 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 3325 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2014 | 82 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 293 | 0.040 |
Why?
|
| Species Specificity | 2 | 2014 | 339 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2016 | 606 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2002 | 498 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 68 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2002 | 192 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1231 | 0.040 |
Why?
|
| Hospices | 1 | 2019 | 39 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 113 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 734 | 0.040 |
Why?
|
| Phenotype | 2 | 2014 | 1233 | 0.030 |
Why?
|
| Hospitals | 1 | 2021 | 397 | 0.030 |
Why?
|
| Mecamylamine | 2 | 2007 | 14 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 532 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 2776 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5643 | 0.030 |
Why?
|
| Infusions, Intraventricular | 1 | 2016 | 12 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1431 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2016 | 21 | 0.030 |
Why?
|
| Odorants | 1 | 2016 | 19 | 0.030 |
Why?
|
| Feeding Behavior | 2 | 2009 | 266 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2015 | 27 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 9 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 230 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2015 | 33 | 0.030 |
Why?
|
| Adult | 4 | 2016 | 17460 | 0.030 |
Why?
|
| Craving | 1 | 2015 | 38 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2632 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 757 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2015 | 102 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 343 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 256 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 312 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 662 | 0.020 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 16 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 1451 | 0.020 |
Why?
|
| Glutamine | 1 | 2012 | 50 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 103 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 674 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1564 | 0.020 |
Why?
|
| Anisotropy | 1 | 2012 | 63 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 399 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 78 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2492 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2012 | 240 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 15051 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 38 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 64 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2009 | 76 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1143 | 0.020 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2008 | 1 | 0.020 |
Why?
|
| Organ of Corti | 1 | 2008 | 3 | 0.020 |
Why?
|
| Hair Cells, Auditory, Inner | 1 | 2008 | 4 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cochlea | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 15 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 87 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 173 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2008 | 23 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 41 | 0.020 |
Why?
|
| Saccharin | 1 | 2008 | 1 | 0.020 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2008 | 3 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2008 | 43 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2009 | 192 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 30 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 193 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 168 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2008 | 20 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 512 | 0.020 |
Why?
|
| Self Stimulation | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2006 | 5 | 0.020 |
Why?
|
| Cotinine | 1 | 2006 | 20 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2006 | 19 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 795 | 0.010 |
Why?
|
| Emotions | 1 | 2008 | 233 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1284 | 0.010 |
Why?
|
| Reward | 1 | 2006 | 89 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1588 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1979 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 405 | 0.010 |
Why?
|
| Castration | 1 | 2004 | 43 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 2004 | 12 | 0.010 |
Why?
|
| United States | 1 | 2017 | 8148 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 165 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 223 | 0.010 |
Why?
|
| Estradiol | 1 | 2004 | 260 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 62 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4836 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 18386 | 0.010 |
Why?
|